|
|
Volumn 18, Issue 2, 2016, Pages 170-173
|
|
10 Questions: Clinical Outlook for iPSCs
a b c d |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE MARROW;
CELL DIFFERENTIATION;
CELL THERAPY;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG REPOSITIONING;
GENE MUTATION;
HEART INFARCTION;
HEART MUSCLE CELL;
HLA SYSTEM;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTERVIEW;
JAPAN;
MACULAR DEGENERATION;
MOTONEURON;
NERVE CELL;
NEUROLOGIC DISEASE;
NONHUMAN;
NOTE;
PARKINSON DISEASE;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
SOMATIC CELL;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TECHNOLOGY;
CLINICAL TRIAL (TOPIC);
CYTOLOGY;
INDUCED PLURIPOTENT STEM CELL;
TRANSLATIONAL RESEARCH;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
HUMANS;
INDUCED PLURIPOTENT STEM CELLS;
REGENERATIVE MEDICINE;
STEM CELL TRANSPLANTATION;
TRANSLATIONAL MEDICAL RESEARCH;
|
|
EID: 84957916622
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2016.01.023 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|